Quality Measurement

Payers typically have no shortage of clinical data at their disposal, with information from health screenings, health assessments, electronic health records (EHRs), clinician notes, test results, and more. But the quality of the data is suspect. In our experience, only about 40% of the clinical data our clients receive from providers or health information exchanges are usable, without need for curation and enrichment. The remaining 60% are inaccurate, incomplete, duplicative, or unstandardized. It requires various levels of curation and enrichment to make data standardized, accurate, and complete.

Black men face many risk factors for being diagnosed with prostate cancer, including a lack of access to healthcare, racial bias that can cause black men not to seek treatment, socioeconomic status, and delayed care. Yet if prostate cancer is detected at the early stages of development, the survival rate is 99%.4 The study's conclusion is that PSA screenings are not only more effective than scientists thought for the general population but benefit black men more than other races. Due to prostate cancer's prevalence in black men, they should be screened earlier and more frequently to monitor and mitigate their risk.